Zhang Rui-Xin, Fan Arthur Yin, Zhou An-Nan, Moudgil Kamal D, Ma Zhong-Ze, Lee David Yue-Wei, Fong Harry H S, Berman Brian M, Lao Lixing
Center for Integrative Medicine, School of Medicine, University of Maryland, 3rd Floor, James Kernan Hospital Man., 2200 Kernan Drive, Baltimore, MD 21207, USA.
J Ethnopharmacol. 2009 Jan 30;121(3):366-71. doi: 10.1016/j.jep.2008.11.018. Epub 2008 Nov 28.
The herbal formula Huo Luo Xiao Ling Dan (HLXL) and its modifications have been used in traditional Chinese medicine for about one hundred years to alleviate pain and inflammation.
To investigate the effects of HLXL on complete Freund's adjuvant (CFA)-induced multiple-joint arthritis in rats.
Male Lewis rats, 190-210 g, were immunized subcutaneously at the base of the tail with 200 microl of heat-killed Mycobacterium tuberculosis in mineral oil (5 mg/ml). HLXL (2.30 and 4.60 g/kg) or vehicle control (n=8 per group) was administered orally (i.g.) once a day between days 16 and 25 post-CFA injection. The rats were observed for signs of arthritis with arthritic changes (erythema, edema, induration) being scored on a scale of 0-4 of increasing severity using a standard scoring system. The maximum arthritis score per rat was 16. A plethysmometer was used to measure edema volume in each paw. Adverse effects of HLXL were monitored by closely observing the animals for unusual behavioral changes. Levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1beta) in local tissue were measured by enzyme-linked immunosorbent assay on day 25 post-CFA.
HLXL significantly decreased arthritis scores between days 23-25 in the 2.30 g/kg group and 21-25 in the 4.60 g/kg group (p<0.05). It reduced paw edema on days 22 and 24 in the 2.30 g/kg group and on days 20, 22 and 24 in the 4.60 g/kg group compared to control (p<0.05). Local tissue TNF-alpha and IL-1beta levels on day 25 post-CFA injection were significantly (p<0.05) lower in rats treated with HLXL than in control rats. No observable adverse effects were found.
The data suggest that HLXL produces significant anti-arthritic effects that may be mediated by suppressing pro-inflammatory cytokines, and it appears to be safe.
中药方剂活络效灵丹(HLXL)及其改良方在传统中医中已使用约百年,用于缓解疼痛和炎症。
研究HLXL对弗氏完全佐剂(CFA)诱导的大鼠多关节关节炎的影响。
190 - 210克雄性Lewis大鼠,在尾根部皮下注射200微升含热灭活结核分枝杆菌(5毫克/毫升)的矿物油进行免疫。在CFA注射后第16至25天,HLXL(2.30和4.60克/千克)或赋形剂对照组(每组n = 8)每日口服给药一次。观察大鼠的关节炎体征,使用标准评分系统对关节炎变化(红斑、水肿、硬结)按严重程度0 - 4分进行评分。每只大鼠的最大关节炎评分为16分。使用体积描记器测量每只爪的水肿体积。通过密切观察动物的异常行为变化来监测HLXL的不良反应。在CFA注射后第25天,通过酶联免疫吸附测定法测量局部组织中肿瘤坏死因子α(TNF-α)和白细胞介素-1β(IL-1β)的水平。
HLXL在2.30克/千克组第23 - 25天以及4.60克/千克组第21 - 25天显著降低关节炎评分(p < 0.05)。与对照组相比,2.30克/千克组在第22和24天以及4.60克/千克组在第20、22和24天爪水肿减轻(p < 0.05)。CFA注射后第25天,HLXL治疗的大鼠局部组织TNF-α和IL-1β水平显著低于对照组(p < 0.05)。未发现明显不良反应。
数据表明HLXL具有显著的抗关节炎作用,可能通过抑制促炎细胞因子介导,且似乎是安全的。